PeptideAnswerPeptideAnswerAsk a question
Anti-Aging & Longevity

Sermorelin

Also called Geref, GHRH 1-29

Sermorelin is the original GHRH fragment - the first twenty-nine amino acids of the natural hormone, which is the part that does the work.

Where this answer comes fromApproved medicine

This one has been through full clinical trials and is an approved medicine somewhere in the world. The ranges below are drawn from those trials and from what the community reports using.

The quick answer

Sermorelin is the original GHRH fragment - the first twenty-nine amino acids of the natural hormone, which is the part that does the work. It was an approved medicine, used in children for years, before it left the market for commercial reasons rather than safety ones.

What it is not

Not growth hormone, and not stronger than the modern analogues. Its case is the record, not the punch.

Why people use it

😴 Sleep quality, the most reported effect; 🕰️ A long human safety record, including in children; 🩹 Recovery; ⚖️ Self-limiting, because the body's own brake still works

What people report using

These are ranges other people have reported running. They are here so you can see what has actually been done — they are not medical advice and not a recommendation for you.

People report running this anywhere from 200mcg to 300mcg, nightly, 5 nights a week.Where somebody sits in that range depends on what they are using it for and what they are starting from — the low end is a deliberate choice a lot of people make, not a half-hearted version of the high end.

Standard — 200–300mcg before bed200–300mcg

Recovery & anti-aging

How often
Nightly, 5 nights a week
Route
subcutaneous
Where this comes from
Approved medicine

Deeper sleep within the first week or two; recovery and skin over a couple of months.

What to expect, and when

Week 1-2: sleep. Month 2: recovery. Month 3 onward: composition, understated.

Side effects, and what people do about them

Injection-site redness, a brief flush, an occasional head-rush. Regarded as the gentlest member of the family.

Go deeper

Open these only if you want them.

How it actually works

GHRH(1-29). Binds the pituitary GHRH receptor and triggers a GH pulse, then clears in ten to twenty minutes. It leaves the feedback loop intact - somatostatin still shuts the pulse down - which is why it is described as difficult to overshoot.

More on the evidence

Was an approved diagnostic/therapeutic agent; withdrawn from the US market commercially, not for safety. VERIFY.

What people report, in full

Sermorelin is what people recommend to someone nervous about starting, and the reason given is always the same: it was a real approved drug given to children for years, so the human safety picture is not a guess. The reported effects are described as real but understated - better sleep in the first couple of weeks, easier recovery by the second month, and not much else that is dramatic. Experienced users tend to say they moved on to the CJC pairing for a stronger effect and fewer injections; the ones who stayed say they stayed because nothing about it ever bothered them. Evening dosing away from food is the universal convention here too, and the "I felt nothing" reports trace back to the same cause.

Worth knowing

The case against

Withdrawn from the US market in 2008 by its manufacturer for commercial reasons. It worked; it stopped selling.

Sources and review

What people report

This record is built on what the wider community reports doing and experiencing, summarised above. No counted dataset has been attached to this compound yet — when one is published, it goes here with its numbers.

References

Once daily subcutaneous GHRH therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. PMID 8772599.

A comparative study of growth hormone and GHRH(1-29)-NH2 for stimulation of growth in children with GH deficiency. PMID 8329830.

These references were located by literature search and recorded as the primary sources behind this record. The publishers block automated retrieval, so they are pointers to the right papers rather than quotations we have checked line by line. They are replaced as we read them properly.

Last reviewed 2026-09-08.

People also look at